CANbridge Life Sciences, Ltd.

Release Summary

China's CANbridge Life Sciences, commercializing Western drugs and devices for unmet medical conditions in China, closed on $25 M in Series B financing. Will use for China trials on 2 cancer drugs.

CANbridge Life Sciences, Ltd.